Clinical Trial Update: Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effects of dupilumab on sense of smell in nasal polyposis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Olfactory Disorders
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Olfactory Disorder | Phase 4 | Status: RECRUITING